Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05169190 · ClinicalTrials.gov registry record · NA

Stellate Ganglion Block for PTSD

A NA study of Post Traumatic Stress Disorder, sponsored by VA Office of Research and Development.

Active
Registry status
NA
Development phase
410
Enrollment target
6
Study locations

NCT05169190 is a NA study of Post Traumatic Stress Disorder that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 410 participants, below the 1,114-participant average among 144 other Post Traumatic Stress Disorder trials with a reported enrollment target (63% lower). The trial reports 6 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05169190, a NA study of Post Traumatic Stress Disorder, is active but no longer recruiting, sponsored by VA Office of Research and Development.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
410 participants
Enrollment target
6
Study locations

Study Summary

Posttraumatic Stress Disorder (PTSD) is a debilitating condition that affects about 15% of Veterans. Current treatments for Veterans with PTSD include medications and psychological therapies that help to process and desensitize to traumatic events. While effective for many, these treatments do not work for all patients, and many may refuse them. Stellate Ganglion Block (SGB), established to treat pain and other conditions, has shown promise for PTSD: early small studies show it may work fast and greatly reduce symptoms. However, data from larger studies are not clear about SGBs effects. A definitive trial is needed, especially for the Veteran population. This large, well-powered, randomized, sham-controlled trial of SGB for PTSD will assess the short-term efficacy of this intervention, the durability of the effects and the safety of the treatment. Additionally, this study will provide critically important information about biological effects of SGB and potential mechanisms of action. This timely study is critical to help VA clinicians better decide about the merits of SGB for PTSD.

Conditions Studied

Post Traumatic Stress Disorder

Interventions

  • PROCEDURE Stellate Ganglion Block
  • PROCEDURE Sham Stellate Ganglion Block

Study Locations (6)

California

  • VA Long Beach Healthcare System, Long Beach, CA - Long Beach

Florida

  • James A. Haley Veterans' Hospital, Tampa, FL - Tampa

Minnesota

  • Minneapolis VA Health Care System, Minneapolis, MN - Minneapolis

Utah

  • VA Salt Lake City Health Care System, Salt Lake City, UT - Salt Lake City

Vermont

  • White River Junction VA Medical Center, White River Junction, VT - White River Junction

Wisconsin

  • William S. Middleton Memorial Veterans Hospital, Madison, WI - Madison

Trial Details

FieldValue
Enrollment Target 410 participants
Start Date 2022-11-17
Est. Completion 2026-06-30
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05169190

The ClinicalTrials.gov registry entry for NCT05169190 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 410 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,114-participant average among 144 other Post Traumatic Stress Disorder trials with a reported enrollment target (63% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 2 interventions - of which Stellate Ganglion Block is the first listed.

NCT05169190 reports 6 study locations spanning 6 distinct geographic areas - top geographies include California, Florida, Minnesota.

Frequently Asked Questions

What is clinical trial NCT05169190 about?

NCT05169190 is a clinical study titled "Stellate Ganglion Block for PTSD". Posttraumatic Stress Disorder (PTSD) is a debilitating condition that affects about 15% of Veterans. Current treatments for Veterans with PTSD include medications and psychological therapies that help to process and desensitize to traumatic events. While effective for many, these treatments do not w...

What is the current status of trial NCT05169190?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 410 participants. The study started on 2022-11-17. Estimated completion is 2026-06-30.

What conditions does trial NCT05169190 study?

This clinical trial studies the following conditions: Post Traumatic Stress Disorder.

What interventions are being tested in trial NCT05169190?

The interventions under investigation include: Stellate Ganglion Block (PROCEDURE), Sham Stellate Ganglion Block (PROCEDURE).

Who is sponsoring clinical trial NCT05169190?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05169190 being conducted?

This trial has 6 study locations across California, Florida, Minnesota, Utah, Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Post Traumatic Stress Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Post Traumatic Stress Disorder

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.